- In June 2021, Bayer AG announced a strategic acquisition of Noria Therapeutics Inc. and PSMA Therapeutics Inc., gaining exclusive rights to the companies' investigational compound. This acquisition is expected to significantly bolster Bayer's oncology portfolio, enabling the company to enhance its research and development capabilities in cancer treatments. By integrating these innovative assets, Bayer aims to address unmet medical needs in oncology and strengthen its market position
- In April 2021, Sanofi revealed its acquisition of Tidal Therapeutics, a pre-clinical biotech firm known for developing a cutting-edge mRNA-based research platform. This acquisition is poised to enhance Sanofi’s research capabilities across oncology, immunology, and other disease areas. By leveraging Tidal's technology, Sanofi aims to accelerate the development of novel therapies, thus reinforcing its commitment to advancing healthcare solutions and addressing various therapeutic challenges
Frequently Asked Questions
The market is segmented based on Segmentation, By Type (4.5 mg, 9 mg, and 13.5mg), Application (Cholangiocarcinoma and Others), Dosage (Tablet and Others), Route of Administration (Oral and Other), End-Users (Clinic, Hospital, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) – Industry Trends and Forecast to 2032
.
The Global Pemigatinib Market size was valued at USD 95.11 USD Million in 2024.
The Global Pemigatinib Market is projected to grow at a CAGR of 9.83% during the forecast period of 2025 to 2032.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
